Robert H. Lurie Comprehensive Cancer Center
Hematology
Dr. Leo Gordon, MD
|
|
Give Review
Dr. Leo Gordon works in the field of Hematology. He studied medicine at University of Cincinnati College of Medicine. He has 4 awards "Meaningful Use Stage 1 Certification", "Fellow (FACP)", "Top MD" and "Super Doctor". Dr. Leo Gordon is a published MD. He has 41 publications published. The most current publication "Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?" He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Bevacizumab for recurrent primary central nervous system lymphoma: a new treatment?
- Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
- Common variants of the G protein-coupled receptor type 4 are associated with human essential hypertension and predict the blood pressure response to angiotensin recept...
- Synthetic high-density lipoprotein-like nanoparticles for Cancer therapy.
- Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
- Blocking tumor escape in hematologic Malignancies: The anti-PD-1 strategy.
- Pidilizumab in the treatment of diffuse large B-cell lymphoma.
- Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes.
- Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-hodgkin lymphoma: a multicentre phase II study.
- Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
- Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
- F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lym...
- Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
- Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
- An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.
- MDCT of Chest, Abdomen, and Pelvis Using Attenuation-Based Automated Tube Voltage Selection in Combination With Iterative Reconstruction: An Intrapatient Study of Radi...
- Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment st...
- Recent advances in mantle cell lymphoma: report of the 2012 Mantle Cell Lymphoma Consortium Workshop.
- Lymphoma Occurring During Pregnancy: Antenatal Therapy, Complications, and Maternal Survival in a Multicenter Analysis.
- Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: A comprehensive analysis from the NCCN lymphoma outcomes project.
- A phase I/II trial of Bortezomib combined concurrently with Gemcitabine for relapsed or refractory DLBCL and Peripheral T-cell lymphomas.
- Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American co-operative group trial.
- Haematological Cancer: Indolent lymphoma-why not to sprint at the start of a marathon.
- Primary CNS Posttransplant Lymphoproliferative Disease (PTLD): An International Report of 84 Cases in the Modern Era.
- Nano-Encapsulation of Arsenic Trioxide Enhances Efficacy against Murine Lymphoma Model while Minimizing Its Impact on Ovarian Reserve In Vitro and In Vivo.
- Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined indu...
- Biomimetic, synthetic HDL nanostructures for lymphoma.
- Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Co...
- The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the N...
- Genetic heterogeneity of diffuse large B-cell lymphoma.
- Mitochondrial-Mediated Apoptosis in Lymphoma Cells by the Diterpenoid Lactone Andrographolide, the Active Component of Andrographis paniculata.
- Curcumin nanodisks: formulation and characterization.
- Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs.
- Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.
- All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of follicular lymphoma: an evidence-based review.
- Motexafin gadolinium enhances p53-Mdm2 interactions, reducing p53 and downstream targets in lymphoma cell lines.
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports ...
- Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized p...
- Yttrium-90 ibritumomab tiuxetan doses calculated to deLiver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in...
Schools
Northwestern University The Feinberg School Of Medicine
Tufts New Eng Med Center
Scripps Clin Rsch Fdn
Procedures Preformed
- Colectomy
- Enterostomy (Laparoscopic or Open)
- Femoral Hernia Repair, Open
- Gallbladder Removal (Cholecystectomy), Laparoscopic
- View All
Conditions Treated
- Abdominal Pain
- Breast Cancer
- Breast Lump
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- General Surgery
- Hematology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
- Fellow (FACP)
- Top MD
- Super Doctor
Education
-
University of Chicago -
University of Cincinnati College of Medicine
Hospital
-
Lurie Children's Hospital of Chicago -
Northwestern Memorial Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1992719918 |
| Last Name Of The Provider | GORDON |
| First Name Of The Provider | LEO |
| View All |
Similar Doctors
|
|
Dr. Phillip R. Fleshner, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Richard Essner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas P. Sokol, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven A. Miles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela M. Lopez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ellen B. Klapper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean M. Lopategui, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Atta M. Nawabi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria L. Delioukina, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Seth I. Felder, MD |
|
|
Dr. Brandice T. Durkan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brent A. Safran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael T. Schmidt, DO |